ArticleMolecular neurobiology2026
Aerobic Exercise Improves Motor Performance by Reducing Total ERK Expression and Hyperexcitability of Striatal D2-MSNs in MPTP-Induced Parkinsonian Mice.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aerobic exercise improves motor dysfunction in Parkinson's disease (PD), but the striatal cell-type-specific mechanisms underlying this effect remain incompletely understood. Here, we investigated whether altered total extracellular signal-regulated kinase (ERK) expression and Mapk1/3-associated functional changes in dorsolateral striatal dopamine D2 receptor-expressing medium spiny neurons (D2-MSNs) are associated with exercise-related functional recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonian mice. Mice underwent four weeks of moderate-intensity treadmill training, followed by behavioral assessment, tyrosine hydroxylase (TH) immunohistochemistry, ERK/PENK immunofluorescence, D2-Cre/DIO-shRNA-mediated Mapk1/3 knockdown, qRT-PCR, and whole-cell patch-clamp recordings. Compared with control mice, MPTP-treated mice showed reduced locomotor activity, shortened stride length, fewer TH-positive neurons in the substantia nigra pars compacta, increased total ERK/PENK double-positive cells in the dorsolateral striatum, and enhanced D2-MSN excitability and excitatory synaptic input. Compared with sedentary MPTP-treated mice, exercise improved open-field and gait performance, increased TH-positive neuronal counts, reduced ERK/PENK double-positive cells, and attenuated D2-MSN hyperexcitability and excessive spontaneous excitatory postsynaptic current frequency and amplitude. Cell-type-targeted Mapk1/3 knockdown reduced Mapk1 and Mapk3 mRNA expression and produced behavioral, histological, molecular, and electrophysiological effects similar to exercise. Combining Mapk1/3 knockdown with exercise did not further enhance these outcomes relative to exercise with scramble control, supporting a non-additive pattern consistent with overlapping Mapk1/3-associated functional mechanisms. Honokiol-based pharmacological perturbation provided additional supportive functional evidence, although these findings were interpreted cautiously because honokiol is pharmacologically pleiotropic and cannot be used to infer ERK activation. Together, these results suggest that modulation of total ERK expression and Mapk1/3-associated functional abnormalities in dorsolateral striatal D2-MSNs may contribute to exercise-associated motor improvement in MPTP-induced parkinsonian mice.
Indexed as
Identifiers
42360561What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.